VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-14.02%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$270M
AUM Growth
+$46.4M
Cap. Flow
+$80.5M
Cap. Flow %
29.85%
Top 10 Hldgs %
7.48%
Holding
501
New
128
Increased
202
Reduced
102
Closed
67

Top Buys

1
O icon
Realty Income
O
+$925K
2
LLY icon
Eli Lilly
LLY
+$843K
3
MRNA icon
Moderna
MRNA
+$824K
4
PFE icon
Pfizer
PFE
+$803K
5
MRK icon
Merck
MRK
+$796K

Top Sells

1
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
+$1.76M
2
AEM icon
Agnico Eagle Mines
AEM
+$1.5M
3
MOS icon
The Mosaic Company
MOS
+$716K
4
STR
Sitio Royalties
STR
+$468K
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$424K

Sector Composition

1 Real Estate 18.55%
2 Healthcare 17.07%
3 Materials 11.98%
4 Financials 11.43%
5 Energy 8.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EXEL icon
276
Exelixis
EXEL
$10.3B
$273K 0.1%
13,133
-8,747
-40% -$182K
MRCC icon
277
Monroe Capital Corp
MRCC
$162M
$272K 0.1%
30,172
+789
+3% +$7.11K
KNSA icon
278
Kiniksa Pharmaceuticals
KNSA
$2.73B
$271K 0.1%
27,992
-2,029
-7% -$19.6K
APLS icon
279
Apellis Pharmaceuticals
APLS
$3.39B
$270K 0.1%
5,970
-2,755
-32% -$125K
NKTR icon
280
Nektar Therapeutics
NKTR
$924M
$270K 0.1%
4,731
+2,775
+142% +$158K
SRPT icon
281
Sarepta Therapeutics
SRPT
$1.85B
$270K 0.1%
3,596
-749
-17% -$56.2K
BMRN icon
282
BioMarin Pharmaceuticals
BMRN
$10.7B
$269K 0.1%
3,246
-1,240
-28% -$103K
OXSQ icon
283
Oxford Square Capital
OXSQ
$172M
$269K 0.1%
73,914
-5,407
-7% -$19.7K
VNDA icon
284
Vanda Pharmaceuticals
VNDA
$266M
$268K 0.1%
24,569
+1,234
+5% +$13.5K
INCY icon
285
Incyte
INCY
$16.7B
$266K 0.1%
3,506
-1,917
-35% -$145K
ASND icon
286
Ascendis Pharma
ASND
$12.3B
$265K 0.1%
2,856
+134
+5% +$12.4K
INSM icon
287
Insmed
INSM
$31.1B
$263K 0.1%
13,344
-525
-4% -$10.3K
BCRX icon
288
BioCryst Pharmaceuticals
BCRX
$1.7B
$260K 0.1%
24,556
-7,986
-25% -$84.6K
SCM icon
289
Stellus Capital Investment Corp
SCM
$420M
$260K 0.1%
23,403
-22,869
-49% -$254K
BNTX icon
290
BioNTech
BNTX
$24.5B
$257K 0.1%
1,721
+377
+28% +$56.3K
BPMC
291
DELISTED
Blueprint Medicines
BPMC
$257K 0.1%
5,089
+1,327
+35% +$67K
IONS icon
292
Ionis Pharmaceuticals
IONS
$10.3B
$256K 0.09%
6,925
-5,371
-44% -$199K
CTIC
293
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$255K 0.09%
+42,735
New +$255K
HRMY icon
294
Harmony Biosciences
HRMY
$1.96B
$254K 0.09%
5,218
-4,468
-46% -$217K
ALNY icon
295
Alnylam Pharmaceuticals
ALNY
$63.2B
$253K 0.09%
1,738
-265
-13% -$38.6K
ROIV icon
296
Roivant Sciences
ROIV
$9.21B
$253K 0.09%
62,129
+43,583
+235% +$177K
UTHR icon
297
United Therapeutics
UTHR
$18.3B
$250K 0.09%
1,063
-855
-45% -$201K
GILD icon
298
Gilead Sciences
GILD
$144B
$248K 0.09%
4,015
-1,259
-24% -$77.8K
NBIX icon
299
Neurocrine Biosciences
NBIX
$14.3B
$248K 0.09%
2,544
-1,953
-43% -$190K
AUPH icon
300
Aurinia Pharmaceuticals
AUPH
$1.63B
$247K 0.09%
24,556
+3,903
+19% +$39.3K
10 11
12
13 14